Transport, transformation and distribution space of propofol in the rat liver studied by means of the indicator-dilution technique

Xenobiotica

Volumn 34, Issue 4, 2004, Pages 317-334

  Acco, A ^a   Bracht, A ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYPROPOFOL; DRUG METABOLITE; GLUCURONIC ACID; PROPOFOL; PROTEIN; SULFATE; UNCLASSIFIED DRUG; WATER;

ANIMAL TISSUE; ARTICLE; CELL LEVEL; CELL MEMBRANE TRANSPORT; CELLULAR DISTRIBUTION; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BINDING; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG TRANSFORMATION; DRUG TRANSPORT; EXTRACELLULAR SPACE; FLOW RATE; INDICATOR DILUTION CURVE; ISOLATED LIVER; LIVER; LIVER FUNCTION; LIVER METABOLISM; LIVER MICROSOME; LIVER MITOCHONDRION; LIVER PERFUSION; MALE; MODEL; NONHUMAN; PORTAL VEIN BLOOD FLOW; RAT; TIME;

ALGORITHMS; ANESTHETICS, INTRAVENOUS; ANIMALS; BIOTRANSFORMATION; CELL MEMBRANE; CELLS, CULTURED; INDICATOR DILUTION TECHNIQUES; LIVER; MALE; METABOLIC CLEARANCE RATE; MICROSOMES, LIVER; MITOCHONDRIA, LIVER; MODELS, BIOLOGICAL; PROPOFOL; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

ANIMALIA; STAPHYLOCOCCUS PHAGE 187;

EID: 2442489938     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/00498250410001658971     Document Type: Article

References (42)

1. BARONI, E., AHUMADA, F., LÜDERS, C., SAAVEDRA, I. and ZAMBUCETTI, R., 2000, Farmacocinética de propofol en potrillos de 10 a 15 dias de edad. Archivos de Medicina Veterinaria, 32, 193-200.
2. BJÖRCK, and DAHLQUIST, G., 1972, Numerische Methoden (Munich: Oldenburg).
3. BRACHT, A., ISHII-IWAMOTO, E. L. and SALGUEIRO-PAGADIGORRIA, C., 2003b, Técnicas de centrifugação e fracionamento celular. In A. Bracht and E. L. Ishii-Iwamoto (eds), Métodos de Laboratório em Bioquímica (São Paulo: Manole), pp. 77-101.
4. BRACHT, A., ISHII-IWAMOTO, E. L. and SALGUEIRO-PAGADIGORRIA, C. L., 2003a, O estudo do metabolismo energético em mitocndrias isoladas de tecido animal. In A. Bracht and E. L. Ishii-Iwamoto (eds), Métodos de Laboratório em Bioquímica (São Paulo: Manole), pp. 227-247.
5. BRACHT, A., SCHWAB, A. J. and SCHOLZ, R., 1980, Untersuchung von Flugeschwindigkeiten in der isoliert perfundierten Rattenleber durch Pulsmarkierung mit radioaktiven Substraten und mathematischer Analyse der Auswaschkinetiken. Hoppe-Seyler's Zeitschrift für Physiologische Chemie, 361, 357-377.
6. BRANCA, D., ROBERTI, M. S., LORENZIN, P., VINCENTI, E. and SCUTARI, G., 1991b, Influence of the anaesthetic 2,6-diisopropylphenol on the oxidative phosphorylation of isolated rat liver mitochondria. Biochemical Pharmacology, 42, 87-90.
7. BRANCA, D., ROBERTI, M. S., VINCENTI, E. and SCUTARI, G., 1991a, Uncoupling effect of the general anaesthetic 2,6-diisopropylphenol in isolated rat liver mitochondria. Archives of Biochemistry and Biophysics, 290, 517-521.
8. COURT, M. H., DUAN, S. X., HESSE, L. M., VENKATAKRISHNAN, K. and GREENBLATT, D. J., 2001, Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. Anesthesiology, 94, 110-119.
9. COURT, M. H., Hay-KRAUS, B. L., HILL, D. W., KIND, A. J. and GREEBBLATT, D. J., 1999, Propofol hydroxylation by dog liver microsomes: assay development and dog breed differences. Drug Metabolism and Disposition, 27, 1293-1299.
10. ENGDAHL, O., ABRAHAMS, M., BJORNSSON, A., VEGFORS, M., NORLANDER, B., AHLNER, J. and EINTREI, C., 1998, Cerebrospinal fluid concentrations of propofol during anaesthesia in humans. British Journal of Anaesthesia, 81, 957-959.
11. FAVETTA, P., GUITTON, J., DEGOUTE, C. S., VAN DAELE, L. and BOULIEU, R., 2000, High-performance liquid chromatographic assay to detect hydroxylate and conjugate metabolites of propofol in human urine. Journal of Chromatography B, 742, 25-35.
12. FERRARESI-FILHO, O., FERRARESI, M. L., CONSTANTIN, J., ISHII-IWAMOTO, E. L., SCHWAB, A. J. and BRACHT, A., 1992, Transport and metabolism of palmitate in the rat liver. Net flux and unidirectional fluxes across the cell membrane. Biochimica et Biophysica Acta, 1103, 239-249.
13. GORESKY, C. A., BACH, G. G. and ROSE, C. P., 1983b, Effects of saturating metabolic uptake on space profiles and tracer kinetics. American Journal of Physiology, 244, G215-G232.
14. GORESKY, C. A., GORDON, E. R. and BACH, G. G., 1983a, Uptake of monohydric alcohols by liver: demonstration of a shared enzymic space. American Journal of Physiology, 244, G198-G214.
15. GORESKY, C. A., ZIEGLER, W. H. and BACH, G. G., 1970, Capillary exchange modelling. Barrier-limited and flow-limited distribution. Circulation Research, 27, 739-764.
16. ISHII, E. L., SCHWAB, A. J. and BRACHT, A., 1987, Inhibition of monosaccharide transport in the intact rat liver by stevioside. Biochemical Pharmacology, 36, 1417-1433.
17. ITINOSE, A. M., DOI-SAKUNO, M. L. and BRACHT, A., 1989, Metabolic effects of acetaminophen. Studies in the isolated perfused rat liver. Cell Biochemistry and Function, 7, 263-273.
18. ITINOSE, A. M., DOI-SAKUNO, M. L. and BRACHT, A., 1995, Induction of paracetamol biotransformation in the rat liver by γ-hexachlorocyclohexane. Research Communications in Alcohol and Substances of Abuse, 16, 177-188.
19. KANTO, J. and GEPTS, E., 1989, Pharmacokinetic implications for the clinical use of propofol. Clinical Pharmacokinetics, 17, 308-206.
20. KELMER-BRACHT, A. M., ISHII-IWAMOTO, E. L. and BRACHT, A., 1993, Transport, distribution space and intracellular concentration of the anti-inflammatory drug niflumic acid in the perfused rat liver. Biochemical Pharmacology, 45, 1863-1871.
21. LARIJANI, G. E., GRATZ, I., AFSHAR, M. and JACOBI, A. G., 1989, Clinical pharmacology of propofol: an intravenous anaesthetic agent. DICP: the Annals of Pharmacotherapy, 23, 743-749.
22. LOPEZ, M. M. and KOSK-KOSICKA, D., 1997, Entropy-driven interactions of anaesthetics with membrane proteins. Biochemistry, 36, 8864-8872.
23. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin reagent. Journal of Biological Chemistry, 193, 265-275.
24. MCGURK, K., BRIERLEY, C. H. and BURCHELL, B., 1998, Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochemical Pharmacology, 55, 1005-1012.
25. MEIER, P. and ZIERLER, K. L., 1954, On the theory of the indicator dilution method for measurement of blood flow and volume. Journal of Applied Physiology, 6, 731-744.
26. MIRENDA, J. and BROYLES, G., 1995, Propofol as used for sedation in the ICU. Chest, 108, 539-548.
27. MOORE, L., CHEN, T., KNAPP, R. and LONDON, E. J., 1975, Energy-dependent calcium sequestration activity in rat liver microsomes. Journal of Biological Chemistry, 250, 4562-4568.
28. RAOOF, A. A., AUGUSTIJNS, P. F. and VERBEECK, R. K., 1996a, In vivo assessment of intestinal, hepatic and pulmonary first pass metabolism of propofol in the rat. Pharmacological Research, 13, 891-895.
29. RAOOF, A. A., OBBERGH, L. J. VAN, VILLE DE GOYET, J. DE and VERBEECK, R. K., 1996b, Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney. European Journal of Clinical Pharmacology, 50, 91-96.
30. SCHOLZ, R. and BÜCHER, T., 1965, Hemoglobin-free perfusion of rat liver. In B. Chance, R. W. Estabrook and J. R. Williamson (eds), Control of Energy Metabolism (New York: Academic Press), pp. 393-414.
31. SERVIN, F., DESMONTS, J. M., HABERER, J. P., COCKSHOTT, I. D., PLUMMER, G. F. and FARINOTTI, R., 1988, Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology, 69, 887-891.
32. SHAFER, S. L., 1993, Advances in propofol pharmacokinetics and pharmacodynamics. Journal of Clinical Anesthesia, 5, 14S-21S.
33. SHAFER, A., DOZE, V. A., SHAFER, S. L. and WHITE, P. F., 1988, Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology, 69, 348-356.
34. SHIMIZU, M., MATSUMOTO, Y., TATSUNO, M. and FUKUOKA, M., 2003, Glucuronidation of propofol and its analogs by human and rat liver microsomes. Biological and Pharmaceutical Bulletin, 26, 216-219.
35. 14C-propofol. Xenobiotica, 21, 1325-1335.
36. TONNER, P. H., POPPERS, D. M. and MILLER, K. W., 1992, The general anesthetic potency of propofol and its dependence on hydrostatic pressure. Anesthesiology, 77, 926-931.
37. TSUCHIYA, H., 2001, Structure-specific membrane-fluidizing effect of propofol. Clinical and Experimental Pharmacology and Physiology, 28, 292-299.
38. VOOS, D. O., CAMPELLO, A. P. and BACILA, M., 1961, The respiratory chain and the oxidative phosphorylation of rat brain mitochondria. Biochemical and Biophysical Research Communications, 4, 48-51.
39. VREE, T. B., LAGERWERF, A. J., BLEEKER, C. P. and DE GROOD, P. M., 1999, Direct high-performance liquid chromatography determination of propofol and its metabolite quinol with their glucuronide conjugates and preliminary pharmacokinetics in plasma and urine of man. Journal of Chromatography B, 721, 217-228.
40. WEAVER, B. M. Q., STADDON, G. E. and MAPLESON, W. W., 2001, Tissue/blood and tissue/water partition coefficients for propofol in sheep. British Journal of Anaesthesia, 86, 693-703.
41. WILKINSON, G. N., 1961, Statistical estimations in enzyme kinetics. Biochemical Journal, 80, 423-332.
42. ZORAN, D. L., RIEDESEL, D. H. and DYER, D. C., 1993, Pharmacokinetics of propofol in mixed-breed dogs and Greyhounds. American Journal of Veterinary Research, 54, 755-760.